Sana Biotechnology, Inc. (SANA) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts SANA Hot Sheet
Join SI Premium – FREE
Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Sana Biotechnology (SANA) PT Lowered to $6 at BofA Securities
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
